The Molecular Diagnostic Raw Enzyme Market is experiencing robust growth as molecular diagnostics become central to precision medicine, infectious disease detection, and genomics-driven healthcare solutions. Valued at US$ 1,298.56 million in 2024, the market is projected to expand at a CAGR of 9.4% from 2025 to 2032. Rising demand for rapid, accurate, and high-throughput diagnostic solutions is...